Stock 301408 ANHUI HUAREN HEALTH PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Anhui Huaren Health Pharmaceutical Co., Ltd.

Equities

301408

CNE100005YT4

Drug Retailers

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-16 pm EDT 		5-day change 1st Jan Change
12.78 CNY +0.79% Intraday chart for Anhui Huaren Health Pharmaceutical Co., Ltd. +0.95% -19.87%
Apr. 28 Anhui Huaren Health Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 15 Anhui Huaren Health Pharmaceutical Co., Ltd. Approves the Election of Independent Directors CI

Valuation

Fiscal Period: December 2023
Capitalization 1 6,380
Enterprise Value (EV) 1 6,413
P/E ratio 55 x
Yield -
Capitalization / Revenue 1.68 x
EV / Revenue 1.69 x
EV / EBITDA 37.6 x
EV / FCF 29,260,372 x
FCF Yield 0%
Price to Book 3.28 x
Nbr of stocks (in thousands) 400,010
Reference price 2 15.95
Announcement Date 4/28/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1,105 1,522 1,931 2,339 3,262 3,797
EBITDA 1 49.3 89.02 130.8 117.3 234.3 170.6
EBIT 1 43.89 82 121.8 106.5 222.5 150.4
Operating Margin 3.97% 5.39% 6.31% 4.56% 6.82% 3.96%
Earnings before Tax (EBT) 1 37.62 77.21 123 94.22 214.7 151.5
Net income 1 19.5 51.95 88.92 69.73 160.8 114.7
Net margin 1.77% 3.41% 4.61% 2.98% 4.93% 3.02%
EPS 2 0.0700 0.1600 0.2600 0.2100 0.4700 0.2900
Free Cash Flow - -56.42 2.702 227.8 128.8 219.2
FCF margin - -3.71% 0.14% 9.74% 3.95% 5.77%
FCF Conversion (EBITDA) - - 2.07% 194.22% 54.98% 128.5%
FCF Conversion (Net income) - - 3.04% 326.73% 80.12% 191.14%
Dividend per Share - - - - - -
Announcement Date 5/7/21 5/7/21 5/7/21 2/9/23 4/10/23 4/28/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - 313 280 32.9
Net Cash position 1 64.2 20.1 120 - - -
Leverage (Debt/EBITDA) - - - 2.667 x 1.195 x 0.1927 x
Free Cash Flow - -56.4 2.7 228 129 219
ROE (net income / shareholders' equity) - 10.6% 14.1% 9.3% 18.5% 8.05%
ROA (Net income/ Total Assets) - 5.04% 6.47% 4.09% 6.12% 2.62%
Assets 1 - 1,030 1,374 1,705 2,628 4,383
Book Value Per Share 2 1.640 1.650 2.100 2.310 2.790 4.860
Cash Flow per Share 2 0.5900 0.4100 0.6100 0.8400 1.420 3.340
Capex 1 22.6 44.1 55.3 33.9 105 216
Capex / Sales 2.05% 2.9% 2.87% 1.45% 3.21% 5.7%
Announcement Date 5/7/21 5/7/21 5/7/21 2/9/23 4/10/23 4/28/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Drug Retailers

1st Jan change Capi.
ANHUI HUAREN HEALTH PHARMACEUTICAL CO., LTD. Stock Anhui Huaren Health Pharmaceutical Co., Ltd.
-19.87% 708M
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-30.37% 15.68B
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-20.59% 12.39B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-21.23% 6.74B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-6.15% 6.29B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
+11.76% 6.26B
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+70.00% 4.95B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
-2.77% 4.66B
CLICKS GROUP LIMITED Stock Clicks Group Limited
-5.58% 4.03B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. Stock DaShenLin Pharmaceutical Group Co., Ltd.
-7.87% 3.62B
Other Drug Retailers
  1. Stock Market
  2. Equities
  3. 301408 Stock
  4. Financials Anhui Huaren Health Pharmaceutical Co., Ltd.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW